The Anti-CCP (anti-cyclic citrullinated peptide antibody) test is a specialized blood test used to detect autoantibodies against citrullinated proteins, which are proteins that have undergone a specific chemical modification. This test is particularly important in the diagnosis of rheumatoid arthritis (RA) and is more specific than the rheumatoid factor (RF) test.
Anti-CCP antibodies can often be detected in the blood years before the onset of clinical symptoms of RA, aiding in early diagnosis. A positive Anti-CCP result, especially when combined with symptoms such as joint pain and swelling, inflammation, and morning stiffness, strongly suggests rheumatoid arthritis. Additionally, a high level of Anti-CCP may be associated with a more aggressive disease course and more severe joint damage.
The test is typically performed using the ELISA (enzyme-linked immunosorbent assay) method, and results are reported as a titer (antibody concentration). However, Anti-CCP positivity can rarely be seen in other autoimmune diseases, such as lupus, or in some infections.
Interpretation of the results should be made alongside clinical evaluation, imaging studies (such as X-ray or MRI), and other tests (such as RF). The Anti-CCP test plays a key role in accurate diagnosis, predicting disease progression, and guiding targeted treatment planning.
